EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Orientin Mitigates High Glucose/Ox‐LDL–Triggered Endothelial Cell Injury and Atherosclerosis by Regulating MARCH8‐Mediated NLRP3 Inflammasome Activation

Qi Li iD, Min Gao iD, Ni Zhong iD, Liang-Rong Zhang iD, Mei-Dong Zhu iD, Wei-Jing Ge iD, Qian-Zhu Wang iD, Xin Chen iD, Lei Zhang iD, Fu-Chen Song iD, Han-Zhi Lu iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/1841497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 27.03.2026. Verfasst von Qi Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese M…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Glucosides, Atherosclerosis, Lipoproteins, LDL. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project, Clinical Science and Technology Innovation Program of Shanghai Shen Kang Hospital Development Center, Advantageous Specialty Construction Project of TCM-Vascular Surgery of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial cells under oxidative stress and inflammation are vital contributors to the progression of atherosclerosis. Although Orientin possesses antioxidant and anti‐inflammatory activities, the effects of Orientin on oxidized low‐density lipoprotein and high glucose (ox‐LDL/HG)–triggered endothelial cell injury and diabetes‐accelerated atherosclerosis remain unclear. ApoE −/− mice were administered streptozotocin (STZ), fed with high‐fat diet (HFD), and then treated with Orientin to test the efficacy of Orientin on ameliorating atherosclerosis through pathological and biochemical assays. Human aortic endothelial cells (HAECs) were stimulated by ox‐LDL/HG followed by Orientin treatment, and the effects of Orientin on regulating HAEC viability, oxidative stress, inflammation, and endothelial‐mesenchymal transition (EndMT) were assessed using cell counting kit‐8 (CCK‐8), fluorescein diacetate (FDA) staining, quantitative real‐time PCR, immunofluorescence (IF), and western blot assays. The results showed that Orientin treatment decreased atherosclerotic plaque burden, lipid lesion, and collagen content in aortic and femoral arteries in diabetic mice. Meanwhile, Orientin alleviated hypercholesterolemia, as evidenced by decreased levels of total cholesterol, LDL‐cholesterol, and triglyceride. In HAECs, Orientin treatment increased cell viability and decreased inflammation, oxidative stress, and EndMT induced by ox‐LDL/HG. Furthermore, Orientin significantly inhibited reactive oxygen species (ROS)–triggered NOD‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and pyroptosis, as suggested by cleavage of caspase‐1 and gasdermin‐D (GSDMD), generation of interleukin (IL)‐18 and IL‐1β, and lactate dehydrogenase (LDH) release. Mechanistically, Orientin increased E3 ubiquitin ligase membrane‐associated RING‐CH 8 (MARCH8) expression in HAECs and resulted in subsequent MARCH8‐mediated ubiquitination and proteasomal degradation of the NLRP3 protein. Taken together, these data demonstrate that Orientin, which alleviates HAEC inflammation and pyroptosis through regulating the MARCH8/NLRP3 axis, might be a potential candidate for treating diabetes‐accelerated atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinGlucosidesAtherosclerosisLipoproteins, LDLFlavonoidsEndothelial CellsInflammasomesGlucoseUbiquitin-Protein LigasesAnimalsMiceHumansMaleOxidative StressMice, Inbred C57BLDiabetes Mellitus, ExperimentalReactive Oxygen Species

Stichwörter der Autor:innen

MARCH8NLRP3Orientinatherosclerosisdiabetesendothelial cell

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinGlucosidesLipoproteins, LDLFlavonoidsorientinInflammasomesoxidized low density lipoproteinGlucoseUbiquitin-Protein LigasesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Vascular Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China, shutcm.edu.cn.
  • Yichuan Community Health Service Center, Putuo District, Shanghai, China.
  • Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China, shutcm.edu.cn.

ORCID-Profile: Qi Li, Min Gao, Ni Zhong, Liang-Rong Zhang, Mei-Dong Zhu, Wei-Jing Ge, Qian-Zhu Wang, Xin Chen, Lei Zhang, Fu-Chen Song, Han-Zhi Lu

Förderung

  • National Science and Technology Major Project
  • Clinical Science and Technology Innovation Program of Shanghai Shen Kang Hospital Development Center
  • Advantageous Specialty Construction Project of TCM-Vascular Surgery of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine

Zitieren

APA

Li, Q., Gao, M., Zhong, N., Zhang, L. R., Zhu, M. D., Ge, W. J., Wang, Q. Z., Chen, X., Zhang, L., Song, F. C., & Lu, H. Z. (2026). Orientin Mitigates High Glucose/Ox‐LDL–Triggered Endothelial Cell Injury and Atherosclerosis by Regulating MARCH8‐Mediated NLRP3 Inflammasome Activation. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/1841497

Vancouver

Li Q, Gao M, Zhong N, Zhang LR, Zhu MD, Ge WJ, et al. Orientin Mitigates High Glucose/Ox‐LDL–Triggered Endothelial Cell Injury and Atherosclerosis by Regulating MARCH8‐Mediated NLRP3 Inflammasome Activation. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/1841497

BibTeX
@article{Li2026,
  author = {Li, Qi and Gao, Min and Zhong, Ni and Zhang, Liang-Rong and Zhu, Mei-Dong and Ge, Wei-Jing and Wang, Qian-Zhu and Chen, Xin and Zhang, Lei and Song, Fu-Chen and Lu, Han-Zhi},
  title = {Orientin Mitigates High Glucose/Ox‐LDL–Triggered Endothelial Cell Injury and Atherosclerosis by Regulating MARCH8‐Mediated NLRP3 Inflammasome Activation},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/1841497}
}
Kostenlos starten →